According to a new global study, 8 in 10 patients hospitalized with COVID-19 develop neurologic complications. Additionally, these patients have greater odds of dying in hospital compared to their counter parts who do not have neurologic complications.

The Global Consortium Study of Neurologic Dysfunction in COVID-19 (GCS-Neuro COVID) noted that around 82% of hospitalized COVID-19 patients had neurologic manifestations and a 6 times greater mortality risk. Of the 3744 patients hospitalized with COVID-19, 82% were found to develop neurological manifestations, with the most common self-reported neurologic symptoms being headache (37%) and anosmia (loss of smell) or ageusia (loss of taste) (26%). Furthermore, the most common neurologic signs and/or syndromes included acute encephalopathy (49%), coma (17%) and stroke (6%). Meningitis and/or encephalitis were found to be rare (0.5%)… (Medscape)